Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Ketones on Cardiac Function in HFrEF
NCT03073356Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 3-hydroxybutyrate in heart failure with reduced ejection fraction (HFrEF), sponsored by Aarhus University. Started Mar 2017; status: completed.
02
Drugs
3-hydroxybutyrate
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT03073356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073356.